Your browser doesn't support javascript.
loading
Tasigna for chronic and accelerated phase Philadelphia chromosome--positive chronic myelogenous leukemia resistant to or intolerant of imatinib.
Hazarika, Maitreyee; Jiang, Xiaoping; Liu, Qi; Lee, Shwu-Luan; Ramchandani, Roshni; Garnett, Christine; Orr, Micheal S; Sridhara, Rajeshwari; Booth, Brian; Leighton, John K; Timmer, William; Harapanhalli, Ravi; Dagher, Ramzi; Justice, Robert; Pazdur, Richard.
Affiliation
  • Hazarika M; Office of Oncology Drug Products, Office of New Drugs, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland 20993, USA.
Clin Cancer Res ; 14(17): 5325-31, 2008 Sep 01.
Article in En | MEDLINE | ID: mdl-18765523
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Protein-Tyrosine Kinases / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Humans Country/Region as subject: America do norte Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2008 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Protein-Tyrosine Kinases / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Humans Country/Region as subject: America do norte Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2008 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos